Anifrolumab

The Anifrolumab PRIM Program

A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus

Anifrolumab for Hidradenitis Suppurativa

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Anifrolumab Malignancy and Serious Infections Study

Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)

Saphnelo Use in Females of Child-bearing Potential

Pharmacokinetic and Safety Study of Subcutaneous and Intravenous Anifrolumab Delivered in Healthy Adult Participants

Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue

Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab